RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Telcon RF Pharmaceutical Stock

Telcon RF Pharmaceutical ROCE 2025

Telcon RF Pharmaceutical ROCE

0.01

Ticker

200230.KQ

ISIN

KR7200230001

In 2025, Telcon RF Pharmaceutical's return on capital employed (ROCE) was 0.01, a -119.13% increase from the -0.05 ROCE in the previous year.

Telcon RF Pharmaceutical Aktienanalyse

What does Telcon RF Pharmaceutical do?

Telcon RF Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Telcon RF Pharmaceutical's Return on Capital Employed (ROCE)

Telcon RF Pharmaceutical's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Telcon RF Pharmaceutical's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Telcon RF Pharmaceutical's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Telcon RF Pharmaceutical’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Telcon RF Pharmaceutical stock

What is the ROCE (Return on Capital Employed) of Telcon RF Pharmaceutical this year?

The ROCE of Telcon RF Pharmaceutical is 0.01 undefined this year.

How has the ROCE (Return on Capital Employed) of Telcon RF Pharmaceutical developed compared to the previous year?

The ROCE of Telcon RF Pharmaceutical has increased by -119.13% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Telcon RF Pharmaceutical?

A high Return on Capital Employed (ROCE) indicates that Telcon RF Pharmaceutical has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Telcon RF Pharmaceutical?

A low ROCE (Return on Capital Employed) can indicate that Telcon RF Pharmaceutical has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Telcon RF Pharmaceutical impact the company?

An increase in the ROCE of Telcon RF Pharmaceutical can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Telcon RF Pharmaceutical affect the company?

A decrease in ROCE of Telcon RF Pharmaceutical can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Telcon RF Pharmaceutical?

Some factors that can affect Telcon RF Pharmaceutical's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Telcon RF Pharmaceutical so important for investors?

The ROCE of Telcon RF Pharmaceutical is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Telcon RF Pharmaceutical take to improve the ROCE?

To improve the ROCE, Telcon RF Pharmaceutical can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Telcon RF Pharmaceutical pay?

Over the past 12 months, Telcon RF Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Telcon RF Pharmaceutical is expected to pay a dividend of 0 KRW.

What is the dividend yield of Telcon RF Pharmaceutical?

The current dividend yield of Telcon RF Pharmaceutical is .

When does Telcon RF Pharmaceutical pay dividends?

Telcon RF Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Telcon RF Pharmaceutical?

Telcon RF Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Telcon RF Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Telcon RF Pharmaceutical located?

Telcon RF Pharmaceutical is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Telcon RF Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Telcon RF Pharmaceutical from 5/7/2025 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 5/7/2025.

When did Telcon RF Pharmaceutical pay the last dividend?

The last dividend was paid out on 5/7/2025.

What was the dividend of Telcon RF Pharmaceutical in the year 2024?

In the year 2024, Telcon RF Pharmaceutical distributed 0 KRW as dividends.

In which currency does Telcon RF Pharmaceutical pay out the dividend?

The dividends of Telcon RF Pharmaceutical are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Telcon RF Pharmaceutical

Our stock analysis for Telcon RF Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Telcon RF Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.